POLARIZABLE FORCE FIELDS FOR PEPTIDES AND PROTEINS

Information

  • Research Project
  • 6180979
  • ApplicationId
    6180979
  • Core Project Number
    R44GM053301
  • Full Project Number
    5R44GM053301-03
  • Serial Number
    53301
  • FOA Number
  • Sub Project Id
  • Project Start Date
    4/18/1996 - 28 years ago
  • Project End Date
    3/31/2001 - 23 years ago
  • Program Officer Name
    WEHRLE, JANNA P.
  • Budget Start Date
    4/1/2000 - 24 years ago
  • Budget End Date
    3/31/2001 - 23 years ago
  • Fiscal Year
    2000
  • Support Year
    3
  • Suffix
  • Award Notice Date
    6/22/2000 - 24 years ago
Organizations

POLARIZABLE FORCE FIELDS FOR PEPTIDES AND PROTEINS

DESCRIPTION: (Adapted form the applicant's abstract) Schrodinger, Inc. proposes to continue developing a novel polarizable force field for proteins and peptides based upon a fluctuating charge (FQ) and dipole model. The force field will include polarizability and solvent effects at a minimal computational cost. Phase I preliminary results show that the FQ model can be fit directly to quantum chemical data for peptides and that the resulting model provides an excellent reproduction of quantum chemical many body energetics of polypeptides. In Phase II, Schrodinger will first use the FQ model to construct a full polarizable force field by constructing a transferable functional form for the electrostatics and then adding van der Waals and valence terms. Secondly, Schrodinger will develop both explicit water and continuum dielectric models of aqueous solvation so that the modeling with the polarizable force field can be carried out in the actual biological environment. The polarizable force field and solvation models will be implemented in a robust molecular modeling code with fast simulation algorithms. Lastly, the force field and simulation algorithms will be rigorously tested to validate that they provide significant improvements over existing fixed charge force fields. PROPOSED COMMERCIAL APPLICATION: NOT AVAILABLE

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R44
  • Administering IC
    GM
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    351348
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    821
  • Ed Inst. Type
  • Funding ICs
    NIGMS:351348\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    SCHRODINGER, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    PORTLAND
  • Organization State
    OR
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    97204
  • Organization District
    UNITED STATES